PDS Biotechnology Corp. (PDSB)
0.2899
-0.01
(-3.37%)
USD |
NASDAQ |
Sep 09, 13:25
PDS Biotechnology Shareholders Equity (Quarterly) : -3.580M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.580M |
| March 31, 2026 | 3.893M |
| December 31, 2025 | 9.252M |
| September 30, 2025 | 9.454M |
| June 30, 2025 | 15.96M |
| March 31, 2025 | 22.36M |
| December 31, 2024 | 19.00M |
| September 30, 2024 | 22.00M |
| June 30, 2024 | 30.92M |
| March 31, 2024 | 37.18M |
| December 31, 2023 | 26.13M |
| September 30, 2023 | 24.48M |
| June 30, 2023 | 32.44M |
| March 31, 2023 | 41.01M |
| December 31, 2022 | 44.00M |
| September 30, 2022 | 47.06M |
| June 30, 2022 | 51.43M |
| March 31, 2022 | 55.87M |
| December 31, 2021 | 63.21M |
| September 30, 2021 | 67.86M |
| June 30, 2021 | 72.99M |
| March 31, 2021 | 24.37M |
| December 31, 2020 | 27.13M |
| September 30, 2020 | 31.02M |
| June 30, 2020 | 17.01M |
| Date | Value |
|---|---|
| March 31, 2020 | 19.89M |
| December 31, 2019 | 11.70M |
| September 30, 2019 | 15.58M |
| June 30, 2019 | 20.61M |
| March 31, 2019 | 24.45M |
| December 31, 2018 | -2.066M |
| September 30, 2018 | 30.98M |
| June 30, 2018 | 33.34M |
| March 31, 2018 | 44.28M |
| December 31, 2017 | 62.37M |
| September 30, 2017 | 74.65M |
| June 30, 2017 | 84.27M |
| March 31, 2017 | 78.65M |
| December 31, 2016 | 89.28M |
| September 30, 2016 | 97.51M |
| June 30, 2016 | 106.76M |
| March 31, 2016 | 114.72M |
| December 31, 2015 | 122.48M |
| September 30, 2015 | 42.62M |
| June 30, 2015 | 52.14M |
| March 31, 2015 | 4.860M |
| December 31, 2014 | 8.955M |
| September 30, 2014 | -2.677M |
| June 30, 2014 | |
| March 31, 2014 | 3.056M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.807M |
| Total Liabilities (Quarterly) | 12.39M |
| Debt to Equity Ratio | -1.219 |
| Current Ratio | 0.5692 |
| Net Debt Paydown Yield | 5.92% |